Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04780217
Title A Clinical Study of Intravenous T3011 Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmVira Pharma Co. Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Phoenix Arizona 85012 United States Details
BRCR Medical Center Inc Plantation Florida 33322 United States Details
Prisma Health - Upstate Greenville South Carolina 29601 United States Details
Virginia Cancer Specialists Greenville South Carolina 29605 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field